✦ LIBER ✦

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

✍ Scribed by Alistair Burns; Roberto Bernabei; Roger Bullock; Alfonso J Cruz Jentoft; Lutz Frölich; Christoph Hock; Minna Raivio; Eric Triau; Maurits Vandewoude; Anders Wimo; Elizabeth Came; Bart Van Baelen; Gerry L Hammond; Joop C van Oene; Susanne Schwalen

Book ID: 114409084
Publisher: The Lancet
Year: 2009
Tongue: English
Weight: 226 KB
Volume: 8
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(08)70261-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The SERAD study of the safety and effica

The SERAD study of the safety and efficacy of galantamine in severe Alzheimer's disease

✍ Martin R Farlow 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 185 KB

Risperidone and rivastigmine and agitate

Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study

✍ Clive Holmes; David Wilkinson; Christine Dean; Corinne Clare; Mohammed El-Okl; C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

A randomised double-blind placebo-contro

A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease

✍ Peter J. Connelly; Neil P. Prentice; Gary Cousland; Jim Bonham 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## Objectives (1) to assess the effect of 1 mg folic acid supplementation of cholinesterase inhibitors (ChI) in a 6 month double‐blind placebo‐controlled study of patients with Alzheimer's Disease (AD) and (2) to assess whether outcome measures were affected by changes in homocysteine

P1-383 Cerebrolysin-efficacy and safety

P1-383 Cerebrolysin-efficacy and safety in moderate to moderately severe Alzheimer's disease: subgroup analysis of a randomized, double-blind, placebo-controlled trial

✍ Herbert Moessler; Antòn X. Álvarez; Ramón Cacabelos 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB

The mad-B study: A randomized, double-bl

The mad-B study: A randomized, double-blind, placebo-controlled trial with cerebrolysin in Alzheimer's disease

✍ Eckhart Ruether; Herbert Moessler; Manfred Windisch 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Ascorbic acid for Charcot–Marie–Tooth di

Ascorbic acid for Charcot–Marie–Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial

✍ Joshua Burns; Robert A Ouvrier; Eppie M Yiu; Pathma D Joseph; Andrew J Kornberg; 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 179 KB